Benefits and risks due to animal serum used in cell culture productionWESSMAN, S. J; LEVINGS, R. L.Developments in biological standardization. 1999, Num 99, pp 3-8, issn 0301-5149Conference Paper

An animal origin perspective of common constituents of serum-free medium formulationsJAYME, D. W.Developments in biological standardization. 1999, Num 99, pp 181-187, issn 0301-5149Conference Paper

Bovine serum : Reducing the variables through the use of donor herdsROLLESTON, W. B. R.Developments in biological standardization. 1999, Num 99, pp 79-86, issn 0301-5149Conference Paper

How much insulin-like growth factor-I (IGF-I) circulates ? : Impact of standardization on IGF-I assay accuracyQUARMBY, V; QUAN, C.Developments in biological standardization. 1999, Num 97, pp 111-118, issn 0301-5149Conference Paper

Cell culture for surveillance of influenzaZAMBON, M.Developments in biological standardization. 1999, Num 98, pp 65-71, issn 0301-5149Conference Paper

Development of a Vero cell-derived influenza whole virus vaccineKISTNER, O; BARRETT, P. N; MUNDT, W et al.Developments in biological standardization. 1999, Num 98, pp 101-110, issn 0301-5149Conference Paper

Regulation of biologicals in the European unionVICARI, G.Developments in biological standardization. 1999, Num 100, pp 145-148, issn 0301-5149Conference Paper

Statistical validity of bioassaysHEATH, A. B.Developments in biological standardization. 1999, Num 97, pp 151-156, issn 0301-5149Conference Paper

The development, benefits and disadvantages of serum-free mediaFROUD, S. J.Developments in biological standardization. 1999, Num 99, pp 157-166, issn 0301-5149Conference Paper

Transmissible spongiform encephalopathy agents and animal seraDORMONT, D.Developments in biological standardization. 1999, Num 99, pp 25-34, issn 0301-5149Conference Paper

Viral validation design of a manufacturing processLARZUL, D.Developments in biological standardization. 1999, Num 99, pp 139-150, issn 0301-5149Conference Paper

WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals : Application to influenza vaccine productionGRIFFITHS, E.Developments in biological standardization. 1999, Num 98, pp 153-157, issn 0301-5149Conference Paper

Alternatives and developing countriesMILSTIEN, J. B; DELLEPIANE, N.Developments in biological standardization. 1999, Num 101, pp 203-208, issn 0301-5149Conference Paper

Evaluation of toxin neutralisation in test systems for diphtheria antibody assessmentVANDENBERG, J; VAN DER GUN, J. W; HENDRIKSEN, C. F. M et al.Developments in biological standardization. 1999, Num 101, pp 105-111, issn 0301-5149Conference Paper

Refinement of in vivo testsMORTON, D. B.Developments in biological standardization. 1999, Num 101, pp 187-193, issn 0301-5149Conference Paper

Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparationsHORMOZI, K; PARTON, R; COOTE, J et al.Developments in biological standardization. 1999, Num 101, pp 147-154, issn 0301-5149Conference Paper

Use of animal testing for evaluating glycoconjugate vaccine immunogenicityMADORE, D. V; STRONG, N; EBY, R et al.Developments in biological standardization. 1999, Num 101, pp 49-56, issn 0301-5149Conference Paper

Vaccines, animals and manRUSSELL, W. M. S.Developments in biological standardization. 1999, Num 101, pp 3-12, issn 0301-5149Conference Paper

Viral veterinary vaccinesPASTORET, P. P; FALIZE, F.Developments in biological standardization. 1999, Num 101, pp 73-78, issn 0301-5149Conference Paper

Detection of authentic SV40 DNA sequences in human brain and bone tumoursBUTEL, J. S; JAFAR, S; STEWART, A. R et al.Developments in biological standardization. 1998, Num 94, pp 23-32, issn 0301-5149Conference Paper

Discovery of simian virus 40 (SV₄₀) and its relationship to poliomyelitis virus vaccinesHILLEMAN, M. R.Developments in biological standardization. 1998, Num 94, pp 183-190, issn 0301-5149Conference Paper

Molecular chaperone function of the SV40 large T antigenPIPAS, J. M.Developments in biological standardization. 1998, Num 94, pp 313-319, issn 0301-5149Conference Paper

Immunotherapy of SV40 induced tumours in mice : A model for vaccine developmentBRIGHT, R. K; SHEARER, M. H; PASS, H. I et al.Developments in biological standardization. 1998, Num 94, pp 341-353, issn 0301-5149Conference Paper

A broad spectrum PCR method for the detection of polyomaviruses and avoidance of contamination by cloning vectorsVÖLTER, C; ZUR HAUSEN, H; ALBER, D et al.Developments in biological standardization. 1998, Num 94, pp 137-142, issn 0301-5149Conference Paper

A respiratory challenge model for infection with Bordetella pertussis : Application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunityMILLS, K. H. G; BRADY, M; RYAN, E et al.Developments in biological standardization. 1998, Num 95, pp 31-41, issn 0301-5149Conference Paper